Global Plasma Fractionation Market - Market Size, Share & Industry Trends, Growth Analysis Report By Product, By Application, By End-User and Forecast 2019 - 2025


DescriptionTable of ContentList of TablesList of Figures
Introduction
Plasma Fractionation Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. The increased awareness amongst people regarding the various liver and chronic related diseases is the major factor fueling the growth of this market. The rising use of immunoglobulins and alpha-1-antitrypsin in medicines is also estimated to increase this market. Additionally, the increasing health care facilities, plasma collection centers and favorable government policies are also identified as drivers of Plasma Fractionation Market.
On the other hand, high cost and limited reimbursements available are some of the restraining factors this Market.
Geographical Overview
At global level, North America region holds the highest market share in 2019 due to the use of immunoglobulin in various therapeutic areas, high medical facilities and rising number of chronic diseases. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of Plasma Fractionation Market with its high population base. Key factors such as changing positive attitude and behavior towards healthcare and favorable government regulations are also driving Plasma Fractionation Market in the Asia Pacific region.?
Segmental Overview
Plasma Fractionation Market is segmented as per below specifications -  
By Product:
•	Protease Inhibitors
•	Albumin
•	Coagulation Factor Concentrates
o	Factor VIII
o	Factor IX
o	Von Willebrand Factor
o	Prothrombin Complex Concentrate
o	Factor XIII
o	Fibrinogen Concentrates
•	Immunoglobulins
o	Intravenous Immunoglobulins
o	Subcutaneous Immunoglobulins
o	Other Immunoglobulins
•	Others
By Application:
•	Immunology
•	Hematology
•	Neurology
•	Rheumatology
•	Pulmonology
•	Others
By End-User:
•	Hospitals and Clinics
•	Clinical Research Laboratories
•	Medical and Academic Institutes
•	Others
Competitor Analysis
Plasma Fractionation Market has presence of some of the key major players across globe which includes
•	Bio Products Laboratory (BPL)
•	Biotest AG
•	China Biologic Products Holdings Inc. 
•	Commonwealth Serum Laboratories (CSL) Limited
•	Green Cross Corporation
•	Grifols S.A.
•	Japan Blood Products Organization
•	Kedrion S.p.A. 
•	LFB Group
•	Octapharma AG
•	Sanquin
•	Shanghai RAAS
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.  
By Geographical Locations: 
•	North America
o	U.S.
o	Canada
•	Europe
o	U.K.
o	France
o	Italy
o	Germany
o	Spain
o	Russia & CIS
o	Rest of Europe
•	Asia-Pacific
o	China 
o	India
o	Japan
o	South Korea
o	ASEAN
o	Rest of Asia Pacific 
•	Latin America
o	Brazil
o	Argentina
o	Rest of LATAM
•	Middle East & Africa
o	UAE
o	South Africa
o	Rest of MEA
?
Highlights of the report
What is Plasma Fractionation Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation 
Market size projection based on Historical & current market trends 
Market share analysis and key strategies adopted by Leading Players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations